Arcadia Biosciences Debt to Equity Ratio 2014-2023 | RKDA
Current and historical debt to equity ratio values for Arcadia Biosciences (RKDA) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Arcadia Biosciences debt/equity for the three months ending December 31, 2023 was 0.00.
| Arcadia Biosciences Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2023-12-31 |
$0.01B |
$0.01B |
0.55 |
| 2023-09-30 |
$0.01B |
$0.02B |
0.52 |
| 2023-06-30 |
$0.01B |
$0.02B |
0.51 |
| 2023-03-31 |
$0.01B |
$0.02B |
0.82 |
| 2022-12-31 |
$0.01B |
$0.02B |
0.38 |
| 2022-09-30 |
$0.01B |
$0.03B |
0.38 |
| 2022-06-30 |
$0.01B |
$0.03B |
0.31 |
| 2022-03-31 |
$0.01B |
$0.03B |
0.28 |
| 2021-12-31 |
$0.01B |
$0.03B |
0.41 |
| 2021-09-30 |
$0.02B |
$0.04B |
0.47 |
| 2021-06-30 |
$0.03B |
$0.04B |
0.66 |
| 2021-03-31 |
$0.03B |
$0.05B |
0.55 |
| 2020-12-31 |
$0.02B |
$0.03B |
0.66 |
| 2020-09-30 |
$0.02B |
$0.01B |
1.82 |
| 2020-06-30 |
$0.02B |
$0.01B |
1.78 |
| 2020-03-31 |
$0.02B |
$0.01B |
1.64 |
| 2019-12-31 |
$0.02B |
$0.01B |
2.91 |
| 2019-09-30 |
$0.02B |
$0.01B |
1.62 |
| 2019-06-30 |
$0.02B |
$0.01B |
2.06 |
| 2019-03-31 |
$0.02B |
$0.00B |
33.68 |
| 2018-12-31 |
$0.01B |
$0.01B |
0.88 |
| 2018-09-30 |
$0.01B |
$0.01B |
1.11 |
| 2018-06-30 |
$0.02B |
$0.01B |
2.83 |
| 2018-03-31 |
$0.02B |
$0.00B |
32.88 |
| 2017-12-31 |
$0.01B |
$0.01B |
1.07 |
| 2017-09-30 |
$0.01B |
$0.01B |
0.78 |
| 2017-06-30 |
$0.03B |
$0.02B |
2.28 |
| 2017-03-31 |
$0.03B |
$0.02B |
1.87 |
| 2016-12-31 |
$0.03B |
$0.02B |
1.55 |
| 2016-09-30 |
$0.03B |
$0.03B |
1.24 |
| 2016-06-30 |
$0.03B |
$0.03B |
1.10 |
| 2016-03-31 |
$0.04B |
$0.04B |
0.98 |
| 2015-12-31 |
$0.03B |
$0.04B |
0.85 |
| 2015-09-30 |
$0.04B |
$0.04B |
0.82 |
| 2015-06-30 |
$0.04B |
$0.05B |
0.77 |
| 2015-03-31 |
$0.03B |
$-0.01B |
-3.66 |
| 2014-12-31 |
$0.03B |
$-0.00B |
-14.20 |
| 2014-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2014-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2014-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2013-12-31 |
$0.03B |
$-0.02B |
-1.55 |
| Sector |
Industry |
Market Cap |
Revenue |
| Basic Materials |
Agricultural Products |
$0.003B |
$0.005B |
|
Arcadia Biosciences, Inc. is engaged in developing and commercializing agricultural products primarily in the United States. The Company's product includes nitrogen use crops, salt tolerant plants, sunflower oil and shelf-life produce. Arcadia Biosciences, Inc. is headquartered in Davis, California.
|
